Prevalence and management of chronic insomnia in Swiss primary care: Cross-sectional data from the "Sentinella" practice-based research network.
chronic insomnia
cognitive behavioural therapy for insomnia
epidemiology
primary care
sleep
Journal
Journal of sleep research
ISSN: 1365-2869
Titre abrégé: J Sleep Res
Pays: England
ID NLM: 9214441
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
22
02
2020
revised:
09
05
2020
accepted:
17
05
2020
pubmed:
27
6
2020
medline:
9
1
2021
entrez:
27
6
2020
Statut:
ppublish
Résumé
We investigated the prevalence and treatment of patients with chronic insomnia presenting to Swiss primary care physicians (PCPs) part of "Sentinella", a nationwide practice-based research network. Each PCP consecutively asked 40 patients if they had sleep complaints, documented frequency, duration, comorbidities, and reported ongoing treatment. We analysed data of 63% (83/132) of the PCPs invited. The PCPs asked 76% (2,432/3,216) of included patients about their sleep (51% female); 31% (761/2,432) of these had had insomnia symptoms; 36% (875/2,432) had current insomnia symptoms; 11% (269/2,432) met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for chronic insomnia (61% female). In all, 75% (201/269) of patients with chronic insomnia had comorbidities, with 49% (99/201) reporting depression. Chronic insomnia was treated in 78% (209/269); 70% (188/268) took medication, 38% (102/268) benzodiazepines or benzodiazepine receptor agonists, 32% (86/268) took antidepressants. Only 1% (three of 268) had been treated with cognitive behavioural therapy for insomnia (CBT-I). A third of patients presenting for a non-urgent visit in Swiss primary care reported insomnia symptoms and 11% met the DSM-5 criteria for chronic insomnia. Hypnotics were the most common treatment, but almost no patients received first-line CBT-I. Reducing the burden of insomnia depends on disseminating knowledge about and access to CBT-I, and encouraging PCPs to discuss it with and offer it as a first-line treatment to patients with chronic insomnia.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13121Informations de copyright
© 2020 European Sleep Research Society.
Références
Agarwal, S. D., & Landon, B. E. (2019). Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Network Open, 2(1), e187399. https://doi.org/10.1001/jamanetworkopen.2018.7399
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, DSM-5. Airlington, VA: American Psychiatric Publishing.
Ancoli-Israel, S., & Roth, T. (1999). Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep, 22(Suppl 2), S347-S353.
Baglioni, C., Altena, E., Bjorvatn, B., Blom, K., Bothelius, K., Devoto, A., … Riemann, D. (2020). The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment. Journal of Sleep Research, 29(2), e12967. https://doi.org/10.1111/jsr.12967
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., … Riemann, D. (2011). Dec). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135(1-3), 10-19. https://doi.org/10.1016/j.jad.2011.01.011
Baglioni, C., Spiegelhalder, K., Nissen, C., & Riemann, D. (2011). Clinical implications of the causal relationship between insomnia and depression: How individually tailored treatment of sleeping difficulties could prevent the onset of depression. The EPMA Journal, 2(3), 287-293. https://doi.org/10.1007/s13167-011-0079-9
Bertisch, S. M., Herzig, S. J., Winkelman, J. W., & Buettner, C. (2014). National use of prescription medications for insomnia: NHANES 1999-2010. Sleep, 37(2), 343-349. https://doi.org/10.5665/sleep.3410
Bjorvatn, B., Meland, E., Flo, E., & Mildestvedt, T. (2017). High prevalence of insomnia and hypnotic use in patients visiting their general practitioner. Family Practice, 34(1), 20-24. https://doi.org/10.1093/fampra/cmw107
Brasure, M., Fuchs, E., MacDonald, R., Nelson, V. A., Koffel, E., Olson, C. M., … Kane, R. L. (2016). Psychological and behavioral interventions for managing insomnia disorder: An evidence report for a clinical practice guideline by the American College of Physicians. Annals of Internal Medicine, 165(2), 113-124. https://doi.org/10.7326/M15-1782
Braun, A. L., Prati, E., Martin, Y., Dvorak, C., Tal, K., Biller-Andorno, N., … Auer, R. (2019). Variation in colorectal cancer testing between primary care physicians: A cross-sectional study in Switzerland. International Journal of Public Health, 64(7), 1075-1083. https://doi.org/10.1007/s00038-019-01259-4
By the American Geriatrics Society Beers Criteria Update Expert Panel (2019). American Geriatrics Society 2019 updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674-694. https://doi.org/10.1111/jgs.15767
Everitt, H., McDermott, L., Leydon, G., Yules, H., Baldwin, D., & Little, P. (2014). GPs' management strategies for patients with insomnia: A survey and qualitative interview study. British Journal of General Practice, 64(619), e112-e119. https://doi.org/10.3399/bjgp14X677176
Gerlach, L. B., Maust, D. T., Leong, S. H., Mavandadi, S., & Oslin, D. W. (2018). Factors associated with long-term benzodiazepine use among older adults. JAMA Internal Medicine, 178(11), 1560-1562. https://doi.org/10.1001/jamainternmed.2018.2413
Hintze, J. P., & Edinger, J. D. (2018). Jun). Hypnotic discontinuation in chronic insomnia. Sleep Medicine Clinics, 13(2), 263-270. https://doi.org/10.1016/j.jsmc.2018.02.008
Hughes, L. D., Raitt, N., Riaz, M. A., Baldwin, S. J., Erskine, K., & Graham, G. (2016). Primary care hypnotic and anxiolytic prescription: Reviewing prescribing practice over 8 years. Journal of Family Medicine and Primary Care, 5(3), 652-657. https://doi.org/10.4103/2249-4863.197312
Koffel, E., Bramoweth, A. D., & Ulmer, C. S. (2018). Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. Journal of General Internal Medicine, 33(6), 955-962. https://doi.org/10.1007/s11606-018-4390-1
Lai, L. L., Tan, M. H., & Lai, Y. C. (2011). Prevalence and factors associated with off-label antidepressant prescriptions for insomnia. Drug, Healthcare and Patient Safety, 3, 27-36. https://doi.org/10.2147/DHPS.S21079
Leger, D., Bayon, V., Ohayon, M. M., Philip, P., Ement, P., Metlaine, A., … Faraut, B. (2014). Insomnia and accidents: Cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. Journal of Sleep Research, 23(2), 143-152. https://doi.org/10.1111/jsr.12104
Leger, D., Partinen, M., Hirshkowitz, M., Chokroverty, S., Hedner, J., & EQUINOX (Evaluation of daytime QUality Impairment by Nocturnal awakenings in Outpatient's eXperience) Survey Investigators. (2010). Characteristics of insomnia in a primary care setting: EQUINOX survey of 5293 insomniacs from 10 countries. Sleep Medicine, 11(10), 987-998. https://doi.org/10.1016/j.sleep.2010.04.019
Leger, D., Partinen, M., Hirshkowitz, M., Chokroverty, S., Touchette, E., Hedner, J., & EQUINOX (Evaluation of daytime QUality Impairment by Nocturnal awakenings in Outpatients eXperience) Survey Investigator Group. (2010). Daytime consequences of insomnia symptoms among outpatients in primary care practice: EQUINOX international survey. . Sleep Medicine, 11(10), 999-1009. https://doi.org/10.1016/j.sleep.2010.04.018
Li, M., Zhang, X. W., Hou, W. S., & Tang, Z. Y. (2014). Oct 20). Insomnia and risk of cardiovascular disease: A meta-analysis of cohort studies. International Journal of Cardiology, 176(3), 1044-1047. https://doi.org/10.1016/j.ijcard.2014.07.284
Maust, D. T., Kales, H. C., Wiechers, I. R., Blow, F. C., & Olfson, M. (2016). No end in sight: Benzodiazepine use in older adults in the United States. Journal of the American Geriatrics Society, 64(12), 2546-2553. https://doi.org/10.1111/jgs.14379
Medalie, L., & Cifu, A. S. (2017). Management of chronic insomnia disorder in adults. JAMA, 317(7), 762-763. https://doi.org/10.1001/jama.2016.19004
Moloney, M. E. (2017). 'Sometimes, it's easier to write the prescription': physician and patient accounts of the reluctant medicalisation of sleeplessness. Sociology of Health & Illness, 39(3), 333-348. https://doi.org/10.1111/1467-9566.12485
Novak, M., Mucsi, I., Shapiro, C. M., Rethelyi, J., & Kopp, M. S. (2004). Increased utilization of health services by insomniacs-an epidemiological perspective. Journal of Psychosomatic Research, 56(5), 527-536. https://doi.org/10.1016/j.jpsychores.2004.02.007
Ohayon, M. M. (2002). Apr). Epidemiology of insomnia: What we know and what we still need to learn. Sleep Medicine Reviews, 6(2), 97-111.
Olfson, M., King, M., & Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA Psychiatry, 72(2), 136-142. https://doi.org/10.1001/jamapsychiatry.2014.1763
Pillai, V., Roth, T., Roehrs, T., Moss, K., Peterson, E. L., & Drake, C. L. (2017). Effectiveness of benzodiazepine receptor agonists in the treatment of Insomnia: An examination of response and remission rates. Sleep, 40(2), https://doi.org/10.1093/sleep/zsw044
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. & Clinical Guidelines Committee of the American College of Physicians. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133. https://doi.org/10.7326/M15-2175
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., … Spiegelhalder, K. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675-700. https://doi.org/10.1111/jsr.12594
Schonmann, Y., Goren, O., Bareket, R., Comaneshter, D., Cohen, A. D., & Vinker, S. (2018). Chronic hypnotic use at 10 years does the brand matter? European Journal of Clinical Pharmacology, 74(12), 1623-1631. https://doi.org/10.1007/s00228-018-2531-4
Ulmer, C. S., Bosworth, H. B., Beckham, J. C., Germain, A., Jeffreys, A. S., Edelman, D., … Voils, C. I. (2017). Veterans affairs primary care provider perceptions of insomnia treatment. Journal of Clinical Sleep Medicine, 13(08), 991-999. https://doi.org/10.5664/jcsm.6702
van Rijswijk, E., Borghuis, M., van de Lisdonk, E., Zitman, F., & van Weel, C. (2007). Treatment of mental health problems in general practice: a survey of psychotropics prescribed and other treatments provided. International Journal of Clinical Pharmacology and Therapeutics, 45(1), 23-29. https://doi.org/10.5414/CPP45023
Walsh, J. K., & Schweitzer, P. K. (1999). Ten-year trends in the pharmacological treatment of insomnia. Sleep, 22(3), 371-375.
Wickwire, E. M., Shaya, F. T., & Scharf, S. M. (2016). Health economics of insomnia treatments: The return on investment for a good night's sleep. Sleep Medicine Reviews, 30, 72-82. https://doi.org/10.1016/j.smrv.2015.11.004
Wickwire, E. M., Tom, S. E., Scharf, S. M., Vadlamani, A., Bulatao, I. G., & Albrecht, J. S. (2019). Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries. Sleep, 42(4), zsz007. https://doi.org/10.1093/sleep/zsz007
Wittchen, H. U., Krause, P., Hofler, M., Pittrow, D., Winter, S., Spiegel, B., … Pfister, H. (2001). [NISAS-2000: The "Nationwide Insomnia Screening and Awareness Study". Prevalence and interventions in primary care]. Fortschritte Der Medizin Originalien, 119(1), 9-19.
Wu, J. Q., Appleman, E. R., Salazar, R. D., & Ong, J. C. (2015). Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: A meta-analysis. JAMA Internal Medicine, 175(9), 1461-1472. https://doi.org/10.1001/jamainternmed.2015.3006
Zheng, B., Yu, C., Lv, J., Guo, Y., Bian, Z., Zhou, M., … Li, L. (2019). Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: A 10-year cohort. Neurology, 93(23), e2110-e2120. https://doi.org/10.1212/WNL.0000000000008581